MMP-9 and CXCL8-IL-8 Are Potential Therapeutic Targets in Epidermolysis Bullosa SimplexReportar como inadecuado

MMP-9 and CXCL8-IL-8 Are Potential Therapeutic Targets in Epidermolysis Bullosa Simplex - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Epidermolysis bullosa refers to a group of genodermatoses that affects the integrity of epithelial layers, phenotypically resulting in severe skin blistering. Dowling-Meara, the major subtype of epidermolysis bullosa simplex, is inherited in an autosomal dominant manner and can be caused by mutations in either the keratin-5 K5 or the keratin-14 K14 gene. Currently, no therapeutic approach is known, and the main objective of this study was to identify novel therapeutic targets. We used microarray analysis, semi-quantitative real-time PCR, western blot and ELISA to identify differentially regulated genes in two K14 mutant cell lines carrying the mutations K14 R125P and K14 R125H, respectively. We found kallikrein-related peptidases and matrix metalloproteinases to be upregulated. We also found elevated expression of chemokines, and we observed deregulation of the Cdc42 pathway as well as aberrant expression of cytokeratins and junction proteins. We further demonstrated, that expression of these genes is dependent on interleukin-1 β signaling. To evaluate these data in vivo we analysed the blister fluids of epidermolysis bullosa simplex patients vs. healthy controls and identified matrix metalloproteinase-9 and the chemokine CXCL8-IL-8 as potential therapeutic targets.

Autor: Thomas Lettner , Roland Lang, Alfred Klausegger, Stefan Hainzl, Johann W. Bauer , Verena Wally



Documentos relacionados